[go: up one dir, main page]

DE19980721D2 - CD4 radioimmunopharmaceuticals used to treat HIV infection - Google Patents

CD4 radioimmunopharmaceuticals used to treat HIV infection

Info

Publication number
DE19980721D2
DE19980721D2 DE19980721T DE19980721T DE19980721D2 DE 19980721 D2 DE19980721 D2 DE 19980721D2 DE 19980721 T DE19980721 T DE 19980721T DE 19980721 T DE19980721 T DE 19980721T DE 19980721 D2 DE19980721 D2 DE 19980721D2
Authority
DE
Germany
Prior art keywords
radioimmunopharmaceuticals
hiv infection
treat hiv
treat
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19980721T
Other languages
German (de)
Inventor
Wolfgang Bergter
Ingrid Corinna Bergter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998126307 external-priority patent/DE19826307A1/en
Application filed by Individual filed Critical Individual
Priority to DE19980721T priority Critical patent/DE19980721D2/en
Application granted granted Critical
Publication of DE19980721D2 publication Critical patent/DE19980721D2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19980721T 1998-04-15 1999-04-15 CD4 radioimmunopharmaceuticals used to treat HIV infection Ceased DE19980721D2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19980721T DE19980721D2 (en) 1998-04-15 1999-04-15 CD4 radioimmunopharmaceuticals used to treat HIV infection

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998126307 DE19826307A1 (en) 1998-03-08 1998-04-15 CD4 radio immunological pharmaceuticals
DE19980721T DE19980721D2 (en) 1998-04-15 1999-04-15 CD4 radioimmunopharmaceuticals used to treat HIV infection
PCT/DE1999/001177 WO1999054954A2 (en) 1998-04-15 1999-04-15 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections

Publications (1)

Publication Number Publication Date
DE19980721D2 true DE19980721D2 (en) 2001-03-29

Family

ID=7870747

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19980721T Ceased DE19980721D2 (en) 1998-04-15 1999-04-15 CD4 radioimmunopharmaceuticals used to treat HIV infection

Country Status (5)

Country Link
EP (1) EP1071475A2 (en)
JP (1) JP2002512261A (en)
AU (1) AU4497199A (en)
DE (1) DE19980721D2 (en)
WO (1) WO1999054954A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0491873A4 (en) * 1989-09-14 1992-10-28 Board Of Regents, The University Of Texas System Therapeutic compositions; methods for treatment of hiv infections
WO1991011461A1 (en) * 1990-01-26 1991-08-08 Biogen, Inc. C4 binding protein fusion proteins
GB9217124D0 (en) * 1992-08-13 1992-09-23 Antisoma Ltd Medical treatment
WO1997003198A2 (en) * 1995-07-07 1997-01-30 Texas A & M University System Nucleotide and amino acid sequence and uses thereof
DE19809785C2 (en) * 1998-03-08 2000-02-10 Wolfgang Bergter Radioimmune drug for the treatment of HIV-1 infection

Also Published As

Publication number Publication date
WO1999054954A3 (en) 2000-01-20
EP1071475A2 (en) 2001-01-31
WO1999054954A2 (en) 1999-10-28
JP2002512261A (en) 2002-04-23
AU4497199A (en) 1999-11-08

Similar Documents

Publication Publication Date Title
DE60219292D1 (en) PYRAZONE DERIVATIVES FOR THE TREATMENT OF HIV
DE60001421D1 (en) EXHAUST TREATMENT
DE69925306D1 (en) TREATMENT OF HYDROCARBONGAS
DE69910781D1 (en) TREATMENT TO REMOVE ODORS
ATE451921T1 (en) PHENYLINDOLES FOR THE TREATMENT OF HIV
ID26043A (en) 1,2,5-TRIAZINA TRITIZED SUBSTITUTIONS FOR TREATMENT OF HIV INFECTIONS
ATE308997T1 (en) AGENTS FOR THE TREATMENT OF DISEASES OF THE ESOPHAUS
DE60019195D1 (en) Treatment by ablation of bone metastases
DE60019556D1 (en) 2-AMINO-BENZOXAZINE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
DE60020820D1 (en) THIADIAZOLYL UREA SUBSTANCES FOR ANTIVIRAL TREATMENT
DE60023043D1 (en) (S, S) reboxetine for the treatment of incontinence
DE60103137D1 (en) Vaccine for the treatment of atherosclerosis
DE60019555D1 (en) 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
ATE323661T1 (en) TREATMENT OF MINERAL SUBSTANCES
DE69926385D1 (en) TREATMENT OF TISSUE
DE69806579D1 (en) PLANT FOR THE TREATMENT OF FOOD
DE60133159D1 (en) VACUUM TREATMENT PLANT
ATE312079T1 (en) NONNUCLEOSIDES REVERSE TRANSCRIPTASE INHIBITORS FOR THE TREATMENT OF HIV INFECTION
DE60140516D1 (en) TREATMENT OF FLUOROLE CARBON OUTPUT MATERIALS
DE60136477D1 (en) RETINOIDES FOR THE TREATMENT OF EMPHYSEM
ATE338552T1 (en) USES OF ET743 TO TREAT CANCER
ATE232378T1 (en) CLEANSING PLASTERS TO IMPROVE SKIN CONDITION
EP1117431A4 (en) TREATMENT OF ACIDOSE
FI935780A (en) HIV protease inhibitors useful in the treatment of AIDS
DE60021065D1 (en) VIRUS TREATMENT

Legal Events

Date Code Title Description
8131 Rejection